We are live on ! Find out more
AC

Alexandria Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+29.48%
3 Year Est. Return
+66.81%
5 Year Est. Return
+126.74%
10 Year Est. Return
–
AUM
$686M
AUM Growth
+$289M
Cap. Flow
+$256M
Cap. Flow %
37.28%
Top 10 Hldgs %
23.94%
Holding
625
New
44
Increased
123
Reduced
47
Closed
391

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.58%
2 Technology 13.48%
3 Healthcare 12.11%
4 Financials 9.38%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
251
Ares Capital
ARCC
$13.8B
– –
-696
Closed -$11K
ASH icon
252
Ashland
ASH
$3.16B
– –
-918
Closed -$60K
ASIX icon
253
AdvanSix
ASIX
$427M
– –
-297
Closed -$12K
AUB icon
254
Atlantic Union Bankshares
AUB
$5.54B
– –
-1,359
Closed -$48K
AVNS
255
DELISTED
Avanos Medical
AVNS
– –
-31
Closed -$1K
AXP icon
256
American Express
AXP
$209B
– –
-571
Closed -$52K
BAX icon
257
Baxter International
BAX
$12.1B
– –
-2,040
Closed -$128K
BB icon
258
BlackBerry
BB
$4.82B
– –
-1,373
Closed -$15K
BBN icon
259
BlackRock Taxable Municipal Bond Trust
BBN
$894M
– –
-1,069
Closed -$25K
BBWI icon
260
Bath & Body Works
BBWI
$3.32B
– –
-168
Closed -$6K
BDX icon
261
Becton Dickinson
BDX
$50.1B
– –
-190
Closed -$36K
BEN icon
262
Franklin Templeton
BEN
$16.8B
– –
-407
Closed -$18K
BHC icon
263
Bausch Health
BHC
$2.13B
– –
-32
Closed –
BKF icon
264
iShares MSCI BIC ETF
BKF
$68.7M
– –
-6
Closed –
BKNG icon
265
Booking.com
BKNG
$123B
– –
-150
Closed -$11K
BMRN icon
266
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-26
Closed -$2K
BNS icon
267
Scotiabank
BNS
$114B
– –
-200
Closed -$13K
BP icon
268
BP
BP
$114B
– –
-1,362
Closed -$47K
BSX icon
269
Boston Scientific
BSX
$63.7B
– –
-238
Closed -$7K
BUD icon
270
AB InBev
BUD
$154B
– –
-79
Closed -$9K
BXP icon
271
Boston Properties
BXP
$10.1B
– –
-1,136
Closed -$140K
BZH icon
272
Beazer Homes USA
BZH
$890M
– –
-3,000
Closed -$56K
C icon
273
Citigroup
C
$225B
– –
-777
Closed -$57K
CABO icon
274
Cable One
CABO
$83.1M
– –
-25
Closed -$18K
CAH icon
275
Cardinal Health
CAH
$51B
– –
-31
Closed -$2K

Similar funds

Alexandria Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Alexandria Capital held 625 positions worth $686M, up 73% from $397M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Alexandria Capital deployed $256M of net new capital in Q4 2017, opening 44 new positions and adding to 123 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 146,417 shares worth $18.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 58% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Mega Cap Value ETF, an estimated $678K trimmed.

  • Alexandria Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 146,417 shares worth $18.6M.
  • Alexandria Capital added most to Adobe in Q4 2017, an estimated $22.3M increase.
  • Alexandria Capital's biggest Q4 2017 reduction was Vanguard Morningstar Mega Cap Value ETF, cutting an estimated $678K.
  • Alexandria Capital fully exited CoStar Group in Q4 2017, selling an estimated $2.05M.
  • Alexandria Capital's ten largest holdings make up 24% of its $686M portfolio in Q4 2017.
  • Alexandria Capital opened 44 new positions and closed 391 in Q4 2017.
  • Alexandria Capital's portfolio value rose 73% quarter-over-quarter to $686M.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.